Finoso Pharma Private Limited, a active private limited company, was established on 18 August 2009 in Hyderabad, Telangana, India. Engaging in pharma contract r&d within the professional, scientific and technical sector, it holds CIN: U24231TG2009PTC064774. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹3.50 Cr and a paid-up capital of ₹3.02 Cr.
It upholds a compliant status. Employing 15 professional, Its leadership includes Aparna Bidarkar (Director), Kunapareddy Devi Prasad (Additional Director), Phaninder Nath Peta Sonti (Additional Director). Past directors included Sandeep Varalwar, Vaidyanathan Mulandram Nateshan, Prashanthi Alamuru. It holds ₹4.50 Cr open charges and ₹2.45 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Sp Biotech Park - Phase-I, Block-I Turkapally, Shameerpet Mandal, Hyderabad, Telangana, 500078.
U24231TG2009PTC064774
064774
18 August 2009
₹3.50 Cr
₹3.02 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Finoso Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Aparna Bidarkar | Director | 05 Jun 2025 | Current |
| Kunapareddy Devi Prasad | Additional Director | 08 Mar 2024 | Current |
| Phaninder Nath Peta Sonti | Additional Director | 16 Jul 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2015 | Past |
| Pramod Abcsdd | Director | 01 Jan 2010 | Past |
| Pramod Abcsdd | Director | 02 Feb 2015 | Past |
| Pramod Abcsdd | Additional Director | 22 Feb 2022 | Past |
| Pramod Abcsdd | Additional Director | 22 Feb 2022 | Past |
| Pramod Abcsdd | Additional Director | 14 Jul 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Finoso Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 71.24% increase. The company also saw a substantial improvement in profitability, with a 39.87% increase in profit. The company's net worth dipped by a decrease of 4.01%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Finoso Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹45,000,000.00
₹24,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Dec 2014 | State Bank Of India | ₹4.50 Cr | Open |
| 28 Oct 2009 | State Bank Of India | ₹2.45 Cr | Satisfied |
Explore comprehensive loan charge details -
Finoso Pharma has a workforce of 15 employees as of Aug 07, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Finoso Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Finoso Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Phaninder Nath Peta Sonti was appointed as a Additional Director was appointed as a Additional Director on 16 Jul 2025 & has been associated with this company since 5 months 6 days . was completed.
Aparna Bidarkar was appointed as a Director was appointed as a Director on 05 Jun 2025 & has been associated with this company since 6 months 17 days . was recorded as a recent event.
The activity Finoso Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Finoso Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.
Kunapareddy Devi Prasad was appointed as a Additional Director was appointed as a Additional Director on 08 Mar 2024 & has been associated with this company since 1 year 9 months . was recorded as a recent event.
The activity A charge with State Bank Of India of Rs. 4.50 Cr registered on 31 Dec 2014 with Charge ID 10549154 was modified on 08 Nov 2017. was completed.
The CIN of Finoso Pharma Private Limited is U24231TG2009PTC064774.
Finoso Pharma Private Limited is headquartered at Sp Biotech Park - Phase-I, Block-I Turkapally, Shameerpet Mandal, Hyderabad, Telangana, 500078.
Finoso Pharma Private Limited was incorporated on 18 August 2009.
The current directors of Finoso Pharma Private Limited are
The primary industry of Finoso Pharma Private Limited is Professional, Scientific And Technical.
Finoso Pharma Private Limited is unlisted.
The authorized capital of Finoso Pharma Private Limited is ₹3.50 Cr, and the paid-up capital is ₹3.02 Cr.
The compliance status of Finoso Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX